ADAMTS13 and thrombotic thrombocytopenic purpura: Using data from a centralized laboratory conducting ADAMTS-13 testing across the province, we estimated TMA incidence and compared the initial clinical presentation of TTP patients and those referred for TMA suspicion before and during the pandemic.